SS
AGIO icon

SBI Securities’s Agios Pharmaceuticals AGIO Stock Holding History

SBI Securities’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19K Sell
32
-1
-3% -$30 ﹤0.01% 2740
2026
Q1 		$1.12K Buy
33
+29
+725% +$822 ﹤0.01% 2617
2025
Q4 		$109 Hold
4
– – ﹤0.01% 3381
2025
Q3 		$161 Buy
4
+1
+33% +$38 ﹤0.01% 3387
2025
Q2 		$100 Hold
3
– – ﹤0.01% 3540
2025
Q1 		$88 Hold
3
– – ﹤0.01% 3484
2024
Q4 		$99 Buy
+3
New +$141 ﹤0.01% 3455

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

SBI Securities's AGIO Position: Q2 2026 in Review

SBI Securities reduced its Agios Pharmaceuticals (AGIO) stake by 3% in Q2 2026, selling an estimated $30 and leaving 32 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

SBI Securities first reported a position in AGIO in Q4 2024 and has held it in 7 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • SBI Securities held 32 shares of Agios Pharmaceuticals worth $1.19K as of Q2 2026.
  • SBI Securities sold 1 Agios Pharmaceuticals share in Q2 2026, an estimated $30.
  • Agios Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2740 holding.
  • SBI Securities first reported a position in Agios Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.